Poster discussion 2 — ASN Events
3:00PM - 4:00PM
Trade Exhibition Hall

#COSAASM

Quality of informed consent in clinical trials (#361)

3:00 PM
Kim Adler

RAINBOW: A global, phase 3, double-blind study of ramucirumab (RAM) plus paclitaxel (PTX) versus placebo (PL) + PTX in the treatment of advanced gastric and gastroesophageal junction (GEJ) adenocarcinoma following disease progression on first-line platinum- and fluoropyrimidine-containing combination therapy: A subgroup analysis of Western population (#362)

3:00 PM
Sumi Ananda

Analysis of adjuvant chemotherapy in early stage Merkel Cell Carcinoma (#363)

3:00 PM
Zia Ansari

P16 Prevalence and incidence of recurrence in different subsites of oropharyngeal cancer: Retrospective analysis at single level institution from 2011-2012 (#364)

3:00 PM
Pawan Bajaj

Significant relationship between MTHFR C677T polymorphism and gastric cancer in Fars (#365)

3:00 PM
Aboozar Barzegar

Serum vitamin A, E, C and catalase in active and passive smokers in Nigeria (#366)

3:00 PM
Iya Eze Bassey

Genetic and epigenetic changes and their effect on prognosis and prediction of colorectal cancer (#367)

3:00 PM
Arpad Bóday

The impact of medical emergency team response on patterns of care at the end-of-life for people with incurable cancer (#368)

3:00 PM
Christine Brown

Assessment of time to commencement of neoadjuvant long course chemoradiotherapy (LCCRT) for locally advanced rectal adenocarcinoma patients in a tertiary referral hospital (#369)

3:00 PM
Hayden Christie

Assessment of long course chemoradiotherapy (LCCRT) in regards to completion of chemotherapy. The experience of a tertiary referral hospital (#370)

3:00 PM
Hayden Christie

Pathologic response of rectal adenocarcinoma to preoperative long course chemoradiotherapy (LCCRT). An assessment at a tertiary referral hospital (#371)

3:00 PM
Hayden Christie

Locally advanced and metastatic pancreatic cancer: An assessment of the provision of chemotherapy at a tertiary referral hospital (#372)

3:00 PM
Hayden Christie

Circulating tumour cells in early stage breast cancer The EMPathy Breast Cancer Network (#373)

3:00 PM
Anthony Dowling

Ipilimumab versus placebo after complete resection of stage III melanoma: efficacy and safety results from the EORTC 18071 phase III trial (#374)

3:00 PM
Alexander M Eggermont

Safety of combined exemestane and everolimus in postmenopausal hormone receptor positive metastatic breast cancer patients – a retrospective analysis (#375)

3:00 PM
Jenny Gilchrist

Merkel cell carcinoma: A case of palliative upper limb amputation in a patient with refractory in-transit metastases. (#376)

3:00 PM
Dakshika A Gunaratne

Comparison and Correlation of Vascular Endothelial Growth Factor (VEGF) Expression in Non Malignant Lesion, Premalignant Lesion and Squamous Cell Carcinoma (SCC) of Oral Cavity (#377)

3:00 PM
Mayank Gupta

Long-term survival of ipilimumab-naïve patients with advanced melanoma (MEL) treated with nivolumab (anti-Programmed Death-1; anti-PD-1; BMS-936558; ONO-4538) in a phase I trial. (#378)

3:00 PM
Stephen Hodi

Safety of treatment of liver carcinoma by percutaneous acetic acid injection: A preliminary report (#379)

3:00 PM
Yuxin Hu

Clinical significance of p53 and 4E molecular marker expression in head and neck squamous cell carcinoma of Northern Territory patients: An Australian retrospective study (#380)

3:00 PM
Rama Dr Jayaraj

Basic physical fitness testing protocol: What can it tell us about women touched by breast cancer? (#381)

3:00 PM
John Keyserlingk

Compliance with international guidelines and readability of informed consent forms for cancer clinical trials (#383)

3:00 PM
James C Kuo

Administration of chemotherapy in patients on dialysis (#384)

3:00 PM
James Kuo

Improving delivery of ambulatory care for cancer patients: experience of the Rapid Assessment Clinic in a tertiary institution (#385)

3:00 PM
Madhawa De Silva

Adjuvant chemotherapy in stage III colon cancer: A regional cancer care centre experience. (#386)

3:00 PM
Andrew Lee

Integration of scientists and clinical experts in Australia’s first molecular tumour board from the Victorian Comprehensive Cancer Centre (VCCC). (#387)

3:00 PM
Belinda M Lee

An initial analysis of preoperative serum microRNA-21 levels for the detection of ovarian carcinoma in patients with a pelvic mass (#388)

3:00 PM
Wei Li

Ki67 expression has prognostic significance in relation to human papillomavirus status in oropharyngeal squamous cell carcinoma (#389)

3:00 PM
Jia Jenny Liu

Plasma miR-320, miR-let-7e and miR-21 as novel potential biomarker for retinoblastoma detection (#390)

3:00 PM
Qiuling Liu

Evaluation of patient characteristics, clinical profile and treatment outcomes in glioblastoma multiforme: An institutional analysis (#391)

3:00 PM
Robert Mason

Nutrition screening and association with chemotherapy outcomes in older cancer patients (#392)

3:00 PM
Alexandra McCarthy

High-Risk Cutaneous Squamous Cell Carcinoma of Head and Neck with Parotid Metastasis: a review of 151 patients Treated at a Tertiary Referral Centre. (#393)

3:00 PM
Lachlan McDowell

Is bevacizumab in metastatic colorectal cancer effectiveness comparable to key Pharmaceutical Benefits Scheme submission clinical trials? Usage results from five large Queensland public hospitals (#394)

3:00 PM
Daniel McKavanagh

Intravenous versus oral flouropyramidine: Post gastrectomy chemoradiation (#395)

3:00 PM
Hamza Mohammed

Doctor-doctor communication of prognosis in metastatic cancer: a review of letters from medical oncologists to referring doctors (#396)

3:00 PM
Erin B Moth

Communication and information processing in patients with primary or metastatic brain malignancy – a survey of practice in two NSW metropolitan radiotherapy centres (#397)

3:00 PM
Diana N Naehrig

Cytokine receptor expression in acute myeloid leukemia: High expression of interleukin-2 receptor α-chain predicts a poor prognosis (#398)

3:00 PM
Kazunori Nakase

Four year outcomes after regional lymphadenectomy for stage III melanoma. (#399)

3:00 PM
Prathyusha Nakka

Response to chemotherapy in patients with gestational trophoblastic neoplasia and subsequent fertility (#400)

3:00 PM
Muralidhar V Pai

Comparison of clinical profile of oral cancers in young and elderly patients - A single institution series from South India (#401)

3:00 PM
Ramya Rangarajan

Fertility preservation toolkit: implementing & evaluating a resource to assist clinical discussion & decision making regarding fertility in paediatric oncology (#402)

3:00 PM
Harene Ranjithakumaran

Melanoma in the elderly, a different spectrum of disease? (#403)

3:00 PM
Matthew J Rees

Operable colorectal liver metastases: An Australian Institution Experience (#404)

3:00 PM
Dhanusha Sabanathan

­Punching above the weight - high-dose methotrexate chemotherapy in extremes of body size (#405)

3:00 PM
Geeta Sandhu

Characteristics and Clinical Outcomes of Invasive Lobular Carcinoma of the Breast (#406)

3:00 PM
Ayesha Saqib

Impact of histopathological profile on 1.5-years disease progression of breast cancer patients: evidence from the Philippine DOH-Breast Cancer Medicine Access Program in medical oncology clinics of two tertiary hospitals (#407)

3:00 PM
Marie Christine G. Semira

Quality of life after cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy for peritoneal carcinomatosis: A systematic review and meta-analysis (#408)

3:00 PM
Bernard L. Shan

Gastrectomy for gastric carcinoma: A systematic review of quality of life (#409)

3:00 PM
Bernard L. Shan

Trans-arterial Embolisation Therapies for Unresectable Intrahepatic Cholangiocarcinoma: A Systematic Review (#410)

3:00 PM
Jocelyn Shan

Assessment of surgical downstaging in an open-label Phase 2 trial of denosumab in patients with Giant Cell Tumour of Bone (#411)

3:00 PM
Paul D Stalley

Survival, response duration, and activity by BRAF mutation (MT) status of nivolumab (NIVO, anti-Programmed Death-1) and ipilimumab (IPI) concurrent therapy in advanced melanoma (MEL). (#412)

3:00 PM
Mario Sznol

Applying social-cognition models to understand women’s hypothetical intentions for Contralateral Prophylactic Mastectomy (#414)

3:00 PM
Stephanie Tesson

Single Institution Review of the Tolerability and Efficacy of Post Chemotherapy Abiraterone Acetate in a Regional Cancer Centre. (#415)

3:00 PM
Padmini thanayankezhil

Rapid fluorodeoxyglucose-positron emission tomography (FDG-PET) response to denosumab treatment in patients with giant cell tumour of bone (GCTB): results from two phase 2 trials (#416)

3:00 PM
David Thomas

Haematological Cancer Patients’ Views on Tissue Banking (#417)

3:00 PM
Heidi Turon

Implementing a protocol for vitamin-D screening and replacement in cancer patients (#420)

3:00 PM
Wen Xu

Training benefits of a Learning Management System (LMS) (#421)

3:00 PM
Eliza Bott

A randomised controlled trial of a couples-based sexuality intervention for men with localised prostate cancer who receive radical prostatectomy and their female partners (#422)

3:00 PM
Suzanne K. Chambers

Appetite for e-learning - educating clinicians on cancer malnutrition  (#423)

3:00 PM
Lauren Muir

Aflibercept in metastatic colorectal cancer (mCRC): Data from clinical trials, lessons from clinical practice (#424)

3:00 PM
Siobhan Ng

Development and implementation of the “Introduction to Oncology for Physiotherapists” study day (#425)

3:00 PM
Sharni L Patchell

Bridging the gap between city and country: A regional interdisciplinary educational workshop and DVD production in head and neck and upper gastrointestinal cancer management (#426)

3:00 PM
Belinda Steer

An examination of prostate cancer trends in Australia, England, Canada and USA: Is the Australian death rate too high? (#427)

3:00 PM
Dane Cole-Clark

Carcinoma tongue a retrospective review of treatment and outcome in 643 patients who had surgery as a primary modality of treatment (#428)

3:00 PM
Nebu George

Risk factors for metachronous colorectal neoplasia: a systematic review and meta-analysis (#429)

3:00 PM
Harindra Jayasekara

Posttraumatic stress disorder and posttraumatic growth in breast cancer patients - a logical analysis (#430)

3:00 PM
Darshit Parikh

A  study on cancer incidence in Nepal from 2003 -2010 (#431)

3:00 PM
Kishore Preadhananga

The Prevalence of Complementary and Alternative Medicine Use Among Patients With Malignancy at Royal Hobart HospitalLowenthal, R, Verma, N 2013 (#432)

3:00 PM
Nidhi Verma

Commencement of an allied health led, pre-radiation treatment group education session for head and neck cancer patients and carers (#433)

3:00 PM
Jessica Abbott

Learning Management System (LMS), the benefits of reporting (#434)

3:00 PM
Eliza Bott

Pazopanib toxicity monitoring (#435)

3:00 PM
Elizabeth A. Connolly

A different direction for social work in assisting those affected by mesothelioma (#436)

3:00 PM
Olga Gountras

Prostatectomy Clinic (#437)

3:00 PM
Sonya Imbesi

A retrospective study on rural oncology patient pathways (#438)

3:00 PM
Talvika Kooblal

The Evolution of a Multidisciplinary Cancer Cachexia Clinic (#439)

3:00 PM
Peter Martin

The Northern Health Outpatient Psycho-Oncology Service: Referral patterns and change in psychological distress over time.  (#440)

3:00 PM
Hunter Mulcare

The highs and lows of the MDT:  Experiences of working in a multidisciplinary team from the perspective of the Prostate Cancer Specialist Nurse in Tamworth, NSW. (#441)

3:00 PM
Sharon L.E. Slack

Outreach Clinic vs. Community Outreach: What’s in a name? A service provision review from the Prostate Cancer Specialist Nurse in Tamworth, NSW. (#442)

3:00 PM
Sharon LE Slack

A model of youth friendly genetic counselling (#443)

3:00 PM
Kate Thompson

Bloomhill Cancer Help: A unique community owned and operated cancer support service model. (#444)

3:00 PM
Merran Z Williams

Investigation of the total and Short Form Patient Generated Subjective Global Assessment (Short Form PG-SGA) score as a screening tool in chemotherapy outpatients (#445)

3:00 PM
Jessica Abbott

A phase III study of the impact of a physical activity program on disease-free survival in patients with high-risk stage II or stage III colon cancer: A randomized controlled trial (NCIC CTG CO.21) (#446)

3:00 PM
Brandi Baylock

The Colon Health And Life-Long Exercise ChaNgE (CHALLENGE) Trial: Participant adherence to fitness assessments (#447)

3:00 PM
Brandi Baylock

The support needs of terminally ill people living alone at home: A narrative review (#448)

3:00 PM
Lauren J Breen

Why do oncology outpatients who report emotional distress decline help? (#449)

3:00 PM
Kerrie Clover

Psychiatry registrars’ views and educational needs regarding the care of patients with life-limiting illnesses (#450)

3:00 PM
Benjamin Forster

Insomnia in cancer (#451)

3:00 PM
Mathew George

Predictors of high levels of distress and unmet needs in carers of High Grade Glioma patients over time (#452)

3:00 PM
Georgia Halkett

Patient, caregiver and healthcare professional’s experiences and perceptions of advance care planning in cancer patients: a systematic review (#453)

3:00 PM
Stephanie Johnson

Suitability of Cancer Registries for Recruiting Patients with Low-Incidence Cancers for Supportive Care Studies (#454)

3:00 PM
Danette H Langbecker

Supporting someone with cancer: the development and implementation of a carer support program at the Olivia Newton-John Cancer & Wellness Centre (ONJCWC). (#456)

3:00 PM
Dianne Legge

Havin’ A Yarn: A project to support Aboriginal people affected by cancer (#457)

3:00 PM
Sue M Merritt

The nurses’ role in monitoring patients with advanced melanoma receiving Ipilimumab in an ambulatory setting at Peter MacCallum cancer centre, Australia (#458)

3:00 PM
Donna Milne

The primacy of quality of life considerations: Meeting the client’s needs. Applying flexibility in the management of secondary lymphoedema in a palliative context (#459)

3:00 PM
Ronna Moore

The impact of an inpatient hospital admission on patient’s physical functioning and quality of life rate in the oncology setting. (#460)

3:00 PM
Andrew Murnane

Implementing a Leisure Activity Maintenance Program into an inpatient cancer setting (#461)

3:00 PM
Jodie Nixon

Scored Patient-Generated Subjective Global Assessment and serum albumin for nutritional assessment of gynecological cancer patients in palliative care (#462)

3:00 PM
Camila S. Rodrigues

Evaluating the utility of the QUAL-EC in the clinical care of patients with advanced cancer (#463)

3:00 PM
Susan Slatyer

What do patients understand about the information they receive during radiotherapy? (#464)

3:00 PM
Haryana Dhillon

Improving malnutrition screening in the radiotherapy setting (#465)

3:00 PM
Belinda Steer

Did the implementation of a prostate cancer specialist nursing service reduce unmet supportive care needs amongst carers? (#466)

3:00 PM
Julie Sykes

Musculoskeletal effects of exercise in men with prostate cancer initiating androgen deprivation therapy (#467)

3:00 PM
Dennis R Taaffe

Supporting Aboriginal and Torres Strait Islander people diagnosed with cancer to navigate the healthcare system (#468)

3:00 PM
Laura Tam

Gastrointestinal mucositis is associated with Muc 2 and 4 expression, and exocytosis of mucin stores (#469)

3:00 PM
Daniel Thorpe

An alternative Medical Services Advisory Committee (MSAC) assessment model: Inherited cancer as an exemplar. (#470)

3:00 PM
Vanessa Tyrrell

Factors associated with preference of communication about life expectancy with physicians among cancer patients under radiation therapy (#471)

3:00 PM
Megumi Uchida

Prevalence of fatigue among cancer patients under radiation therapy and its associated factors (#472)

3:00 PM
Megumi Uchida

Is crofelemer an effective intervention for dacomitinib-induced gastrointestinal toxicity?  (#473)

3:00 PM
Ysabella Van Sebille

"Undressing" distress among cancer patients and carers in regional Western Australia (#474)

3:00 PM
Kaaren J Watts

Item generation and content validity testing of the Health Literacy of Caregivers Scale-Cancer (HeLiCaS-C)  (#475)

3:00 PM
Eva YN Yuen